Mark VanRaden
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Virology top 2%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS Research and Interventions 4
- SARS-CoV-2 and COVID-19 Research 2
- Viral Infections and Outbreaks Research 2
-
- HIV, Drug Use, Sexual Risk 3
- Co-authors
- Richard A. Kaslow (6 shared papers)Lawrence Kingsley (6 shared papers)John Phair (3 shared papers)Roger Detels (3 shared papers)Cathy Conry‐Cantilena (2 shared papers)Jacqueline C. Melpolder (2 shared papers)Harvey J. Alter (2 shared papers)Joan Gibble (1 shared paper)
- Journals
- New England Journal of Medicine (2 papers)The Lancet (2 papers)Vaccine (2 papers)American Journal of Public Health (1 paper)Clinical Trials (1 paper)
- Partner nations
- United StatesVietnamSpain
In The Last Decade
Mark VanRaden
20 papers receiving 1.8k citations
Mark VanRaden's Hit Papers
Peers
Comparison fields: 5 of 109
- Hepatology 431
- Virology 264
- Parasitology 353
- Infectious Diseases 785
- Epidemiology 628
Countries citing papers authored by Mark VanRaden
This map shows the geographic impact of Mark VanRaden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark VanRaden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark VanRaden more than expected).
Fields of papers citing papers by Mark VanRaden
This network shows the impact of papers produced by Mark VanRaden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark VanRaden. The network helps show where Mark VanRaden may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark VanRaden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection Hit paper breakdown → | 1996 | 509 |
| 2 | 2006 | 266 | |
| 3 | 1987 | 248 | |
| 4 | 1989 | 172 | |
| 5 | 1990 | 166 | |
| 6 | 2007 | 100 | |
| 7 | 1990 | 92 | |
| 8 | 1990 | 72 | |
| 9 | 1991 | 66 | |
| 10 | 2014 | 56 | |
| 11 | 1990 | 36 | |
| 12 | 2018 | 15 | |
| 13 | 2013 | 13 | |
| 14 | 2016 | 11 | |
| 15 | 2016 | 10 | |
| 16 | 2017 | 8 | |
| 17 | 1993 | 6 | |
| 18 | 1995 | 5 | |
| 19 | 2006 | 1 | |
| 20 | Estimation of pertussis vaccine efficacy in the presence of covariates in three randomized trials. | 1997 | 1 |
About Mark VanRaden
Mark VanRaden is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Virology and Critical Care and Intensive Care Medicine, having authored 20 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (4 papers), HIV Research and Treatment (3 papers), HIV, Drug Use, Sexual Risk (3 papers), Vector-borne infectious diseases (2 papers), Hepatitis C virus research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Viral Infections and Outbreaks Research (2 papers) and Thermal Regulation in Medicine (2 papers). The work is most often cited by research in Hepatology (431 citations), Virology (264 citations), Parasitology (353 citations), Infectious Diseases (785 citations) and Epidemiology (628 citations). Mark VanRaden has collaborated with scholars based in United States, Vietnam and Spain. Frequent co-authors include Richard A. Kaslow, Lawrence Kingsley, John Phair, Roger Detels, Cathy Conry‐Cantilena, Jacqueline C. Melpolder, Harvey J. Alter, Joan Gibble, A DIBISCEGLIE and L Viladomiu. Their work appears in journals such as New England Journal of Medicine, The Lancet, Vaccine, American Journal of Public Health and Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.